(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients.

The company is also pinning its hopes on its ability to cross-sell the devices to hospitals and doctors who prescribe their drugs. Patel said Zydus is not only looking at organic growth but is ...

Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram. The medication ...

Zydus Lifesciences share price today, March 13: The share price of Zydus Lifesciences has cracked 2.6% in the last five days. (Image: Freepik) Nuvama Institutional Equities slashed the target ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...

Like our moon, Deimos is tidally locked to Mars, meaning the same side always faces the planet—the only side visible to ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences has entered exclusive negotiations ... “We want to offer services beyond just medicines, so whether it is medical devices which are highly technologically oriented or ...

Zydus Lifesciences Limited ( ($IN:ZYDUSLIFE) ) has shared an update. Zydus Lifesciences Limited has received final approval from the USFDA to ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...